I chose this specialty because of the many exciting new therapeutic options for patients with genitourinary cancers, as well as the opportunity to become an integral part of a team that cares for patients during one of their most difficult times.

As my patient, you can depend on me for compassion and dedication, in addition to an innovative and patient-centered approach to care. My research interests are clinical trials for genitourinary cancers and cancer survivorship research. During my free time, I enjoy running, hiking, cooking and travel.

Conditions I Treat

- Prostate cancer
- Bladder cancer
- Testicular cancer
- Kidney cancer
- Adrenal cancer

Certified Specialties

Medical Oncology - American Board of Internal Medicine

Faculty Appointments

Professor - Department of Medicine, Hematology/Oncology (SMD)

Associate Chair, Diversity, Equity and Inclusion - Department of Medicine (SMD)

Professor - Cancer Center - Joint

Professor - Department of Public Health Sciences (SMD) - Joint

Credentials

Residency & Fellowship

Fellowship, Hematology & Oncology, Abramson Cancer Center of the University of Pennsylvania. 2008 - 2011

Residency, Internal Medicine, Hospital of the University of Pennsylvania. 2005 - 2007

Internship, Internal Medicine, Hospital of the University of Pennsylvania. 2004 - 2005

Education

MD | University of Pennsylvania School of Medicine. 2004

Awards

Human Rights Campaign Leadership Award for Rising Star Gala Leaders. 2020

Presidential Diversity Award Nominee, University of Rochester. 2019

Civic Leadership Award. 2018 - 2018

URMC Wilmot Cancer Institute, Hematology/Oncology Fellowship Training Program, Teacher of the Year 2017/2018. 2018

Strong Star Certificate of Appreciation. 2016

Empire Clinical Research Investigator Program Fellowship Grant. 2016 - 2018

Strong Star Certificate of Appreciation. 2015

Strong Star Certificate of Appreciation. 2014

Strong Star Certificate of Appreciation. 2013

Wimot Cancer Center Research Fellowship. 2012 - 2015

Strong Star Certificate of Appreciation. 2012

Patient and Family Centered Care Award. 2012

National Institute of Health Loan Repayment Program Grant. 2012

American Society of Clinical Oncology Trainee Travel Award. 2011

National Institute of Health Loan Repayment Program. 2010

NCCN Fellow Recognition Program. 2010

American Heart Association Cardiovascular Disease and Stroke Fellowship. 2001

Summa Cum Laude with Distinction in Research. 2000

Golden Key National Honor Society. 2000

Howard Hughes Medical Institute Undergraduate Research Scholarship. 1999

Valedictorian. 1996

Research

I am a medical oncologist specialized in genitourinary malignancy and an Assistant Professor of medicine with research interests in cancer control, particularly in the development, implementation, and dissemination of mHealth behavioral interventions to prevent and manage treatment- and cancer-related toxicities in cancer survivors, with a specific focus in cardiovascular complications from cancer treatment. Additionally, I am interested in developing clinical trials to evaluate new therapeutics for treatment of urologic malignancies.

Clinical Trials

Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer

Lead Researcher: Chunkit Fung

This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addi...

DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC).,DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC).,DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC).,DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC).,DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC).,DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC).,DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC).,DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC).

Lead Researcher: Chunkit Fung

The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. Earlier studies helped show that the combination is safe, but the combination has not been ...

Publications

Journal Articles

Disparities in the cancer continuum experienced by transgender and gender-diverse patients: A rapid review.

Stamm LE, Stojanovski K, Insalaco ME, Wright L, Kamen C, Fung C

Cancer.. 2025 March 1131 (5):e35788. Epub 1900 01 01.

Factors associated with longitudinal progression of the cumulative burden of morbidity and overall mortality after cisplatin-based chemotherapy for testicular cancer.

Kerns SL, Dinh PC, Monahan PO, Stump T, Fung C, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Huddart R, Kollmannsberger C, Martin NE, Nevel K, Kincaid J, Einhorn LH, Travis LB

Journal of the National Cancer Institute.. 2025 February 3 Epub 02/03/2025.

Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer.

Powles T, Catto JWF, Galsky MD, Al-Ahmadie H, Meeks JJ, Nishiyama H, Vu TQ, Antonuzzo L, Wiechno P, Atduev V, Kann AG, Kim TH, Suárez C, Chang CH, Roghmann F, Özgüro?lu M, Eigl BJ, Oliveira N, Buchler T, Gadot M, Zakharia Y, Armstrong J, Gupta A, Hois S, van der Heijden MS,

The New England journal of medicine.. 2024 November 14391 (19):1773-1786. Epub 09/15/2024.

Cognitive function in long-term testicular cancer survivors: impact of modifiable factors.

Dinh PC, Monahan PO, Fung C, Sesso HD, Feldman DR, Vaughn DJ, Hamilton RJ, Huddart R, Martin NE, Kollmannsberger C, Althouse S, Einhorn LH, Frisina R, Root JC, Ahles TA, Travis LB

JNCI cancer spectrum.. 2024 September 28 (5)Epub 1900 01 01.

High-dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCT.

Peppone LJ, Kleckner AS, Fung C, Puzas JE, Reschke JE, Culakova E, Inglis J, Kamen C, Friedberg JW, Janelsins M, Mustian K, Heckler CE, Mohile S

Cancer.. 2024 July 15130 (14):2538-2551. Epub 03/23/2024.

Comprehensive Audiologic Analyses After Cisplatin-Based Chemotherapy.

Sanchez VA, Dinh PC, Monahan PO, Althouse S, Rooker J, Sesso HD, Dolan ME, Weinzerl M, Feldman DR, Fung C, Einhorn LH, Frisina RD, Travis LB

JAMA oncology.. 2024 July 110 (7):912-922. Epub 1900 01 01.

Impact of pain and adverse health outcomes on long-term US testicular cancer survivors.

Dinh PC, Monahan PO, Fosså SD, Sesso HD, Feldman DR, Dolan ME, Nevel K, Kincaid J, Vaughn DJ, Martin NE, Sanchez VA, Einhorn LH, Frisina R, Fung C, Kroenke K, Travis LB

Journal of the National Cancer Institute.. 2024 March 7116 (3):455-467. Epub 1900 01 01.

Adolescent and Young Adult Germ Cell Tumors: Epidemiology, Genomics, Treatment, and Survivorship.

Travis LB, Feldman DR, Fung C, Poynter JN, Lockley M, Frazier AL

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2024 February 2042 (6):696-706. Epub 10/11/2023.

Coverage for evidence-based cancer survivorship care services.

Blaes AH, Abu-Khalaf MM, Bender CM, Dent SF, Fung C, Smith SK, Watson S, Katta S, Merrill JK, Hudson SV

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2024 February 1732 (3):165. Epub 02/17/2024.

State of Cancer Care in America: Achieving Cancer Health Equity Among Sexual and Gender Minority Communities.

Kamen CS, Dizon DS, Fung C, Pratt-Chapman ML, Agulnik M, Fashoyin-Aje LA, Jeames SE, Merrill JK, Smith KT, Maingi S

JCO oncology practice.. 2023 November 19 (11):959-966. Epub 10/04/2023.

Cardiovascular Risks in Testicular Cancer: Assessment, Prevention, and Treatment.

Clasen SC, Fung C, Sesso HD, Travis LB

Current oncology reports.. 2023 May 25 (5):445-454. Epub 03/03/2023.

Patient-Reported Functional Impairment Due to Hearing Loss and Tinnitus After Cisplatin-Based Chemotherapy.

Sanchez VA, Shuey MM, Dinh PC, Monahan PO, Fosså SD, Sesso HD, Dolan ME, Einhorn LH, Vaughn DJ, Martin NE, Feldman DR, Kroenke K, Fung C, Frisina RD, Travis LB

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2023 April 2041 (12):2211-2226. Epub 01/10/2023.

Lack of hydroxyurea-associated mutagenesis in pediatric sickle cell disease patients.

Torous DK, Avlasevich S, Bemis JC, Howard T, Ware RE, Fung C, Chen Y, Sahsrabudhe D, MacGregor JT, Dertinger SD

Environmental and molecular mutagenesis.. 2023 March 64 (3):167-175. Epub 03/15/2023.

Rucaparib or Physician's Choice in Metastatic Prostate Cancer.

Fizazi K, Piulats JM, Reaume MN, Ostler P, McDermott R, Gingerich JR, Pintus E, Sridhar SS, Bambury RM, Emmenegger U, Lindberg H, Morris D, Nolè F, Staffurth J, Redfern C, Sáez MI, Abida W, Daugaard G, Heidenreich A, Krieger L, Sautois B, Loehr A, Despain D, Heyes CA, Watkins SP, Chowdhury S, Ryan CJ, Bryce AH,

The New England journal of medicine.. 2023 February 23388 (8):719-732. Epub 02/16/2023.

Comprehensive association analysis of speech recognition thresholds after cisplatin-based chemotherapy in survivors of adult-onset cancer.

Shahbazi M, Zhang X, Dinh PC, Sanchez VA, Trendowski MR, Shuey MM, Nguyen T, , Feldman DR, Vaughn DJ, Fung C, Kollmannsberger C, Martin NE, Einhorn LH, Cox NJ, Frisina RD, Travis LB, Dolan ME

Cancer medicine. 2023 February 12 (3):2999-3012. Epub 09/12/2022.

Prevalence and risk factors for ototoxicity after cisplatin-based chemotherapy.

Sanchez VA, Dinh PC, Rooker J, Monahan PO, Althouse SK, Fung C, Sesso HD, Einhorn LH, Dolan ME, Frisina RD, Travis LB

Journal of cancer survivorship : research and practice.. 2023 February 17 (1):27-39. Epub 01/13/2023.

Effect of Yoga and Mediational Influence of Fatigue on Walking, Physical Activity, and Quality of Life Among Cancer Survivors.

Lin PJ, Altman BJ, Gilmore NJ, Loh KP, Dunne RF, Bautista J, Fung C, Janelsins MC, Peppone LJ, Melnik MK, Gococo KO, Messino MJ, Mustian KM

Journal of the National Comprehensive Cancer Network : JNCCN.. 2023 February 21 (2):153-162.e2. Epub 1900 01 01.

AGS and NIA bench-to bedside conference summary: Cancer and cardiovascular disease.

Mohile S, Blaum CS, Abadir PM, Dale W, Forman DE, Fung C, Holmes HM, Moslehi J, Mustian KM, Rich MW, Whitson HE

Journal of the American Geriatrics Society.. 2022 October 70 (10):2764-2774. Epub 06/11/2022.

Medicare Accountable Care Organizations: Post-acute Care Use and Post-surgical Outcomes in Urologic Cancer Surgery.

Katragadda C, Fung C, Yousefi-Nooraie R, Cupertino P, Joseph J, Kim Y, Li Y

Urology.. 2022 September 167 :102-108. Epub 06/28/2022.

How to Manage Cisplatin-Based Chemotherapy-Related Cardiovascular Disease in Patients With Testicular Cancer.

Kadambi S, Clasen SC, Fung C

JACC. CardioOncology.. 2022 September 4 (3):409-412. Epub 09/20/2022.

Pharmacogenomics of cisplatin-induced neurotoxicities: Hearing loss, tinnitus, and peripheral sensory neuropathy.

Zhang X, Trendowski MR, Wilkinson E, Shahbazi M, Dinh PC, Shuey MM, , Feldman DR, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Huddart R, Martin NE, Sanchez VA, Frisina RD, Einhorn LH, Cox NJ, Travis LB, Dolan ME

Cancer medicine. 2022 July 11 (14):2801-2816. Epub 03/23/2022.

Re: Thyroid hypofunction in aging testicular cancer survivors.

Fung C, Dinh PC, Travis LB

Acta oncologica.. 2022 March 61 (3):386-387. Epub 01/10/2022.

Ototoxicity After Cisplatin-Based Chemotherapy: Factors Associated With Discrepancies Between Patient-Reported Outcomes and Audiometric Assessments.

Ardeshirrouhanifard S, Fossa SD, Huddart R, Monahan PO, Fung C, Song Y, Dolan ME, Feldman DR, Hamilton RJ, Vaughn D, Martin NE, Kollmannsberger C, Dinh P, Einhorn L, Frisina RD, Travis LB

Ear and hearing.. 2022 43 (3):794-807. Epub 1900 01 01.

Increased risk of high-grade prostate cancer among testicular cancer survivors.

Zhang H, Yang H, Bandyopadhyay S, Milano MT, Fung C, Messing EM, Chen Y

PloS one.. 2022 17 (2):e0263573. Epub 02/14/2022.

Testicular Cancer Survivorship: Looking Back to Move Forward.

Fung C, Travis LB

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2021 November 1039 (32):3531-3534. Epub 09/30/2021.

Cisplatin, environmental metals, and cardiovascular disease: an urgent need to understand underlying mechanisms.

Clasen SC, Dinh PC, Hou L, Fung C, Sesso HD, Travis LB

Cardio-oncology.. 2021 October 107 (1):34. Epub 10/10/2021.

Tobacco Dependence Treatment: Examining Cessation Effectiveness in Oncology Settings.

Mallaber P, Fung C, Strawderman M, Knapp-Clevenger R, Williams GC

Clinical journal of oncology nursing.. 2021 August 125 (4):479-482. Epub 1900 01 01.

Pembrolizumab alone or combined with chemotherapy versus chemotherapy as first-line therapy for advanced urothelial carcinoma (KEYNOTE-361): a randomised, open-label, phase 3 trial.

Powles T, Cs?szi T, Özgüro?lu M, Matsubara N, Géczi L, Cheng SY, Fradet Y, Oudard S, Vulsteke C, Morales Barrera R, Fléchon A, Gunduz S, Loriot Y, Rodriguez-Vida A, Mamtani R, Yu EY, Nam K, Imai K, Homet Moreno B, Alva A,

The Lancet. Oncology.. 2021 July 22 (7):931-945. Epub 05/26/2021.

Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study.

ArdeshirRouhaniFard S, Dinh PC, Monahan PO, Fossa SD, Huddart R, Fung C, Song Y, Feldman DR, Hamilton RJ, Vaughn DJ, Martin NE, Kollmannsberger C, Einhorn L, Kroenke K, Travis LB

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.. 2021 June 30 (6):1129-1138. Epub 04/13/2021.

Surviving Testicular Cancer: The Role of the Contralateral Testicle.

D'souza A, Van Veldhuizen P, Fung C

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2021 February 139 (4):265-268. Epub 1900 01 01.

Clinical and Genome-Wide Analysis of Multiple Severe Cisplatin-Induced Neurotoxicities in Adult-Onset Cancer Survivors.

Trendowski MR, Wheeler HE, El Charif O, Feldman DR, Hamilton R, Vaughn DJ, Fung C, Kollmannsberger C, Einhorn LH, Travis LB, Dolan ME

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2020 December 1526 (24):6550-6558. Epub 09/30/2020.

Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors.

Kerns SL, Fung C, Fossa SD, Dinh PC, Monahan P, Sesso HD, Frisina RD, Feldman DR, Hamilton RJ, Vaughn D, Martin N, Huddart R, Kollmannsberger C, Sahasrabudhe D, Ardeshir-Rouhani-Fard S, Einhorn L, Travis LB

JNCI cancer spectrum.. 2020 August 4 (4):pkaa022. Epub 03/20/2020.

Solid and Hematologic Neoplasms After Testicular Cancer: A US Population-Based Study of 24?900 Survivors.

Milano MT, Dinh PC, Yang H, Zaid MA, Fossa SD, Feldman DR, Monahan PO, Travis LB, Fung C

JNCI cancer spectrum.. 2020 June 4 (3):pkaa017. Epub 03/17/2020.

Increased Risk of Cardiovascular Sequelae in Survivors of Male Germ Cell Cancer.

Clasen SC, Fung C, Dinh PC, Travis LB

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2020 May 138 (13):1497-1498. Epub 03/18/2020.

The association of delay in curative intent treatment with survival among breast cancer patients: findings from the Women's Health Initiative.

Yung R, Ray RM, Roth J, Johnson L, Warnick G, Anderson GL, Kroenke CH, Chlebowski RT, Simon MS, Fung C, Pan K, Wang D, Barrington WE, Reding KW

Breast cancer research and treatment.. 2020 April 180 (3):747-757. Epub 02/15/2020.

Adverse Health Outcomes Among US Testicular Cancer Survivors After Cisplatin-Based Chemotherapy vs Surgical Management.

Agrawal V, Dinh PC, Fung C, Monahan PO, Althouse SK, Norton K, Cary C, Einhorn L, Fossa SD, Adra N, Travis LB

JNCI cancer spectrum.. 2020 April 4 (2):pkz079. Epub 10/08/2019.

Effects of exercise on inflammation in patients receiving chemotherapy: a nationwide NCORP randomized clinical trial.

Kleckner IR, Kamen C, Cole C, Fung C, Heckler CE, Guido JJ, Culakova E, Onitilo AA, Conlin A, Kuebler JP, Mohile S, Janelsins M, Mustian KM

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2019 December 27 (12):4615-4625. Epub 04/02/2019.

Testicular Cancer Survivorship.

Fung C, Dinh PC, Fossa SD, Travis LB

Journal of the National Comprehensive Cancer Network : JNCCN.. 2019 December 17 (12):1557-1568. Epub 1900 01 01.

Clinical and Genome-Wide Analysis of Serum Platinum Levels after Cisplatin-Based Chemotherapy.

Trendowski MR, El Charif O, Ratain MJ, Monahan P, Mu Z, Wheeler HE, Dinh PC, Feldman DR, ArdeshirRouhaniFard S, Hamilton R, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Hannigan R, Strathmann FG, Einhorn LH, Fossa SD, Travis LB, Dolan ME

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2019 October 125 (19):5913-5924. Epub 07/11/2019.

Clinical and Genome-wide Analysis of Cisplatin-induced Tinnitus Implicates Novel Ototoxic Mechanisms.

El Charif O, Mapes B, Trendowski MR, Wheeler HE, Wing C, Dinh PC, Frisina RD, Feldman DR, Hamilton RJ, Vaughn DJ, Fung C, Kollmannsberger C, Mushiroda T, Kubo M, Gamazon ER, Cox NJ, Huddart R, Ardeshir-Rouhani-Fard S, Monahan P, Fossa SD, Einhorn LH, Travis LB, Dolan ME

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2019 July 125 (13):4104-4116. Epub 04/05/2019.

Adverse Health Outcomes in Relationship to Hypogonadism After Chemotherapy: A Multicenter Study of Testicular Cancer Survivors.

Abu Zaid M, Dinh PC, Monahan PO, Fung C, El-Charif O, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Sesso HD, Huddart R, Mushiroda T, Kubo M, Dolan ME, Einhorn LH, Fossa SD, Travis LB,

Journal of the National Comprehensive Cancer Network : JNCCN.. 2019 May 117 (5):459-468. Epub 1900 01 01.

Efficacy of Split Schedule Versus Conventional Schedule Neoadjuvant Cisplatin-Based Chemotherapy for Muscle-Invasive Bladder Cancer.

Osterman CK, Babu DS, Geynisman DM, Lewis B, Somer RA, Balar AV, Zibelman MR, Guancial EA, Antinori G, Yu S, Narayan V, Guzzo TJ, Plimack ER, Vaughn DJ, Fung C, Mamtani R

The oncologist.. 2019 May 24 (5):688-690. Epub 02/06/2019.

Effects of a Home-based Exercise Program on Anxiety and Mood Disturbances in Older Adults with Cancer Receiving Chemotherapy.

Loh KP, Kleckner IR, Lin PJ, Mohile SG, Canin BE, Flannery MA, Fung C, Dunne RF, Bautista J, Culakova E, Kleckner AS, Peppone LJ, Janelsins M, McHugh C, Conlin A, Cho JK, Kasbari S, Esparaz BT, Kuebler JP, Mustian KM

Journal of the American Geriatrics Society.. 2019 May 67 (5):1005-1011. Epub 1900 01 01.

Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Rini BI, Plimack ER, Stus V, Gafanov R, Hawkins R, Nosov D, Pouliot F, Alekseev B, Soulières D, Melichar B, Vynnychenko I, Kryzhanivska A, Bondarenko I, Azevedo SJ, Borchiellini D, Szczylik C, Markus M, McDermott RS, Bedke J, Tartas S, Chang YH, Tamada S, Shou Q, Perini RF, Chen M, Atkins MB, Powles T,

The New England journal of medicine.. 2019 March 21380 (12):1116-1127. Epub 02/16/2019.

Response to Crevenna and Ashbury, Vallance and Bolam, and Crevenna and Keilani regarding the effects of exercise on chemotherapy-induced peripheral neuropathy.

Kleckner IR, Kamen C, Gewandter JS, Mohile NA, Heckler CE, Culakova E, Fung C, Janelsins MC, Asare M, Lin PJ, Reddy PS, Giguere J, Berenberg J, Kesler SR, Mustian KM

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2019 January 27 (1):7-8. Epub 10/29/2018.

Systematic Review of Randomized Controlled Trials of Exercise Interventions Using Digital Activity Trackers in Patients With Cancer.

Schaffer K, Panneerselvam N, Loh KP, Herrmann R, Kleckner IR, Dunne RF, Lin PJ, Heckler CE, Gerbino N, Bruckner LB, Storozynsky E, Ky B, Baran A, Mohile SG, Mustian KM, Fung C

Journal of the National Comprehensive Cancer Network : JNCCN.. 2019 January 17 (1):57-63. Epub 1900 01 01.

Risk of solid cancer after chemotherapy.

Fung C, Travis LB

Nature reviews. Urology.. 2018 November 15 (11):660-661. Epub 1900 01 01.

A Festschrift in Honor of Edward M. Messing, MD, FACS.

Joseph JV, Brasacchio R, Fung C, Reeder J, Bylund K, Sahasrabudhe D, Yeh SY, Ghazi A, Fultz P, Rubens D, Wu G, Singer E, Schwarz E, Mohile S, Mohler J, Theodorescu D, Lee YF, Okunieff P, McConkey D, Rashid H, Chang C, Fradet Y, Guru K, Kukreja J, Sufrin G, Lotan Y, Bailey H, Noyes K, Schwartz S, Rideout K, Bratslavsky G, Campbell SC, Derweesh I, Abrahamsson PA, Soloway M, Gomella L, Golijanin D, Svatek R, Frye T, Lerner S, Palapattu G, Wilding G, Droller M, Trump D

Bladder cancer.. 2018 October 34 (Suppl 1):S1-S43. Epub 10/03/2018.

Predicting Cardiovascular Disease Among Testicular Cancer Survivors After Modern Cisplatin-based Chemotherapy: Application of the Framingham Risk Score.

Feldman DR, Ardeshir-Rouhani-Fard S, Monahan P, Sesso HD, Fung C, Williams AM, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Zaid MA, Lipshultz SE, Einhorn LH, Oeffinger KC, Travis LB, Fossa SD,

Clinical genitourinary cancer.. 2018 August 16 (4):e761-e769. Epub 02/05/2018.

Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study.

Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid MI, Williams AM, Stump TE, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger C, Sahasrabudhe DM, Cook R, Fossa SD, Einhorn LH, Travis LB,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2018 May 2036 (15):1505-1512. Epub 04/04/2018.

A population-based study of prognosis and survival in patients with second primary thyroid cancer after Hodgkin lymphoma.

Chowdhry AK, Fung C, Chowdhry VK, Bergsma D, Dhakal S, Constine LS, Milano MT

Leukemia & lymphoma.. 2018 May 59 (5):1180-1187. Epub 09/01/2017.

Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial.

Kleckner IR, Kamen C, Gewandter JS, Mohile NA, Heckler CE, Culakova E, Fung C, Janelsins MC, Asare M, Lin PJ, Reddy PS, Giguere J, Berenberg J, Kesler SR, Mustian KM

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer.. 2018 April 26 (4):1019-1028. Epub 12/14/2017.

Clinical and Genetic Risk Factors for Adverse Metabolic Outcomes in North American Testicular Cancer Survivors.

Zaid MA, Gathirua-Mwangi WG, Fung C, Monahan PO, El-Charif O, Williams AM, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Cook R, Althouse SK, Ardeshir-Rouhani-Fard S, Dinh PC, Sesso HD, Einhorn LH, Fossa SD, Travis LB,

Journal of the National Comprehensive Cancer Network : JNCCN.. 2018 March 16 (3):257-265. Epub 1900 01 01.

Yoga for the Management of Cancer Treatment-Related Toxicities.

Lin PJ, Peppone LJ, Janelsins MC, Mohile SG, Kamen CS, Kleckner IR, Fung C, Asare M, Cole CL, Culakova E, Mustian KM

Current oncology reports.. 2018 February 120 (1):5. Epub 02/01/2018.

Toxicities Associated with Cisplatin-Based Chemotherapy and Radiotherapy in Long-Term Testicular Cancer Survivors.

Fung C, Dinh P, Ardeshir-Rouhani-Fard S, Schaffer K, Fossa SD, Travis LB

Advances in urology.. 2018 2018 :8671832. Epub 02/18/2018.

Exercise for Toxicity Management in Cancer-A Narrative Review.

Kleckner IR, Dunne RF, Asare M, Cole C, Fleming F, Fung C, Lin PJ, Mustian KM

Oncology & hematology review.. 2018 14 (1):28-37. Epub 02/15/2018.

Management and outcomes of patients with renal medullary carcinoma: a multicentre collaborative study.

Shah AY, Karam JA, Malouf GG, Rao P, Lim ZD, Jonasch E, Xiao L, Gao J, Vaishampayan UN, Heng DY, Plimack ER, Guancial EA, Fung C, Lowas SR, Tamboli P, Sircar K, Matin SF, Kimryn Rathmell W, Wood CG, Tannir NM

BJU international.. 2017 December 120 (6):782-792. Epub 12/09/2016.

Clinical and Genome-Wide Analysis of Cisplatin-Induced Peripheral Neuropathy in Survivors of Adult-Onset Cancer.

Dolan ME, El Charif O, Wheeler HE, Gamazon ER, Ardeshir-Rouhani-Fard S, Monahan P, Feldman DR, Hamilton R, Vaughn DJ, Beard C, Fung C, Fossa SD, Hertz DL, Mushiroda T, Kubo M, Einhorn LH, Cox N, Travis L

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2017 October 123 (19):5757-5768. Epub 06/13/2017.

Novel Therapies in Platinum-refractory Metastatic Germ Cell Tumor: A Case Report with a Focus on a PD-1 Inhibitor.

Loh KP, Fung C

Rare tumors.. 2017 July 39 (2):6867. Epub 07/03/2017.

Variants in and Other Mendelian Deafness Genes Are Associated with Cisplatin-Associated Ototoxicity.

Wheeler HE, Gamazon ER, Frisina R, Perez-Cervantes C, El Charif O, Mapes B, Fossa SD, Feldman D, Hamilton R, Vaughn DJ, Beard C, Fung C, Kollmannsberger C, Kim J, Mushiroda T, Kubo M, Ardeshir-Rouhani-Fard S, Einhorn LH, Cox N, Dolan ME, Travis L

Clinical cancer research : an official journal of the American Association for Cancer Research.. 2017 July 123 (13):3325-3333. Epub 12/30/2016.

Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy.

Fung C, Sesso HD, Williams AM, Kerns SL, Monahan P, Abu Zaid M, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Kollmannsberger CK, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Lipshultz SE, Einhorn LH, Fossa SD, Travis LB,

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2017 April 1035 (11):1211-1222. Epub 02/27/2017.

Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer Treatments.

Mustian KM, Cole CL, Lin PJ, Asare M, Fung C, Janelsins MC, Kamen CS, Peppone LJ, Magnuson A

Seminars in oncology nursing.. 2016 November 32 (4):383-393. Epub 10/21/2016.

Treatment of Metastatic Prostate Cancer in Older Adults.

Loh KP, Mohile SG, Kessler E, Fung C

Current oncology reports.. 2016 October 18 (10):63. Epub 1900 01 01.

Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer.

Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, Monahan PO, Feldman DR, Hamilton R, Vaughn DJ, Beard CJ, Budnick A, Johnson EM, Ardeshir-Rouhani-Fard S, Einhorn LH, Lipshultz SE, Dolan ME, Travis LB

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2016 August 1034 (23):2712-20. Epub 06/27/2016.

Targeted Therapy Based on Tumor Genomic Analyses in Metastatic Urachal Carcinoma.

Loh KP, Mondo E, Hansen EA, Sievert L, Fung C, Sahasrabudhe DM, Guancial E

Clinical genitourinary cancer.. 2016 August 14 (4):e449-52. Epub 03/24/2016.

Association of falls with health-related quality of life (HRQOL) in older cancer survivors: A population based study.

Pandya C, Magnuson A, Dale W, Lowenstein L, Fung C, Mohile SG

Journal of geriatric oncology.. 2016 May 7 (3):201-10. Epub 02/18/2016.

Reply to S. Alanee et al.

Fung C, Fossa SD, Milano MT, Sahasrabudhe DM, Peterson DR, Travis LB

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2016 April 1034 (11):1285-6. Epub 02/08/2016.

Novel physical activity interventions for older patients with prostate cancer on hormone therapy: A pilot randomized study.

Sajid S, Dale W, Mustian K, Kotwal A, Heckler C, Porto M, Fung C, Mohile SG

Journal of geriatric oncology.. 2016 March 7 (2):71-80. Epub 02/23/2016.

Cardiovascular Disease Mortality After Chemotherapy or Surgery for Testicular Nonseminoma: A Population-Based Study.

Fung C, Fossa SD, Milano MT, Sahasrabudhe DM, Peterson DR, Travis LB

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2015 October 133 (28):3105-15. Epub 08/03/2015.

Secondary malignant neoplasms in testicular cancer survivors.

Curreri SA, Fung C, Beard CJ

Urologic oncology.. 2015 September 33 (9):392-8. Epub 06/11/2015.

Long-term Morbidity of Testicular Cancer Treatment.

Fung C, Fossa SD, Williams A, Travis LB

The Urologic clinics of North America.. 2015 August 42 (3):393-408. Epub 06/10/2015.

Second primary head and neck cancer after Hodgkin lymphoma: a population-based study of 44,879 survivors of Hodgkin lymphoma.

Chowdhry AK, McHugh C, Fung C, Dhakal S, Constine LS, Milano MT

Cancer.. 2015 May 1121 (9):1436-45. Epub 01/08/2015.

Bladder cancer in the elderly patient: challenges and solutions.

Guancial EA, Roussel B, Bergsma DP, Bylund KC, Sahasrabudhe D, Messing E, Mohile SG, Fung C

Clinical interventions in aging.. 2015 10 :939-49. Epub 06/10/2015.

Impact of bladder cancer on health related quality of life in 1,476 older Americans: a cross-sectional study.

Fung C, Pandya C, Guancial E, Noyes K, Sahasrabudhe DM, Messing EM, Mohile SG

The Journal of urology.. 2014 September 192 (3):690-5. Epub 04/01/2014.

Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis.

Vitek WS, Shayne M, Hoeger K, Han Y, Messing S, Fung C

Fertility and sterility.. 2014 September 102 (3):808-815.e1. Epub 07/17/2014.

Prostate cancer in the elderly patient.

Fung C, Dale W, Mohile SG

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2014 August 2032 (24):2523-30. Epub 1900 01 01.

Reply to G. Gandaglia et al.

Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2014 April 1032 (11):1167-9. Epub 03/03/2014.

A case series of transformation of teratoma to primitive neuroectodermal tumor: evolving management of a rare malignancy.

Dunne RF, Sahasrabudhe DM, Messing EM, Jean-Gilles J, Fung C

Rare tumors.. 2014 January 236 (1):5268. Epub 03/18/2014.

Androgen deprivation therapy and cardiovascular risk in prostate cancer

Fung, C; Guancial, E.

Contemporary Oncology. 2014; 6(2): 6-11.

Solid tumors after chemotherapy or surgery for testicular nonseminoma: a population-based study.

Fung C, Fossa SD, Milano MT, Oldenburg J, Travis LB

Journal of clinical oncology : official journal of the American Society of Clinical Oncology.. 2013 October 2031 (30):3807-14. Epub 09/16/2013.

Second malignant neoplasms in testicular cancer survivors.

Fung C, Fossa SD, Beard CJ, Travis LB

Journal of the National Comprehensive Cancer Network : JNCCN.. 2012 April 10 (4):545-56. Epub 1900 01 01.

Chemotherapy refractory testicular germ cell tumor is associated with a variant in Armadillo Repeat gene deleted in Velco-Cardio-Facial syndrome (ARVCF).

Fung C, Vaughn DJ, Mitra N, Ciosek SL, Vardhanabhuti S, Nathanson KL, Kanetsky PA

Frontiers in endocrinology.. 2012 3 :163. Epub 12/13/2012.

Adjuvant and neoadjuvant therapies in high-risk renal cell carcinoma.

Smaldone MC, Fung C, Uzzo RG, Haas NB

Hematology/oncology clinics of North America.. 2011 August 25 (4):765-91. Epub 1900 01 01.

Complications associated with chemotherapy in testicular cancer management.

Fung C, Vaughn DJ

Nature reviews. Urology.. 2011 April 8 (4):213-22. Epub 03/15/2011.

Books

Cancer: Principles & Practice of Oncology, 11th Edition (2017)

Chapter: Second Cancers

Authors: Fung, C., Bhatia, S., Allan, J.M., Oeffinger, K.C., Ng, A., Travis L.B.

Publisher: Wolters Kluwer Health, Philadelphia 2017

Testicular Cancer: Diagnosis and Clinical Management (2014)

Chapter: Second Malignant Neoplasms and Cardiovascular Disease Among Testicular Cancer Survivors

Authors: Fung, C., Fossa SD, Travis LB

Publisher: Oxford: Blackwell Publishing 2014

EAU-ICUD Consultation on Medical Treatment of Urological Malignancies (2014)

Chapter: Second Malignant Neoplasms Among Testicular Cancer Survivors

Authors: Fung, C., Travis, LB, Warde

Publisher: EAU-ICUD 2014

EAU-ICUD Consultation on Medical Treatment of Urological Malignancies (2014)

Chapter: Neurotoxicity and Ototoxicity Among Testicular Cancer Survivors

Authors: Fung, C., Qi, J, Oldenburg, J

Publisher: EAU-ICUD 2014

ALERT-Adverse Late Effects of Cancer Treatment (2013)

Chapter: Biotoxicity of Chemotherapy

Authors: Fung, C., Pandya KJ

Publisher: Springer Publication, New York 2013

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.

Ratings

Care provider's discussion of any proposed treatment (options, risks, benefits, etc.)

4.9

Likelihood of recommending this care provider to others

4.9

Explanations the care provider gave you about your problem or condition

4.9

Care provider's efforts to include you in decisions about your care

4.9

Concern the care provider showed for your questions or worries

4.9

Patient Comments

5.0

Great uplifting and compassionate experience.

Jan 22, 2025

5.0

Dr. Chunkit Fung is a remarkable physician, highly skilled and one that inspires confidence. He spent more than sufficient time with me reviewing scans and blood work results. My daughter attended via speaker phone with my smartphone and he made sure her questions and concerns were addressed as well. Furthermore, he felt that the results of my scans and blood work reflected changes in my [...] and consequently consulted with my hematologist, Dr. Clive Zent. Dr. Zent in turn moved up my scheduled appointment by two months. I am most appreciative that Dr. Fung communicates with my other doctors.

Jan 22, 2025

5.0

My oncologist has been excellent in managing my care. He follows NIH guidelines, shares those with me and involves me in all decisions. I trust his judgement and rely on his expertise.I would highly recommend him to others in need of a urological oncologist.

Jan 08, 2025

5.0

Dr Fung is excellent

Dec 04, 2024

5.0

I feel that I am getting the best care possible. My questions are answered quickly and my opinion is respected.

Nov 18, 2024

5.0

Good experience, I left very satisfied

Aug 07, 2024

5.0

Dr. Fung is excellent. I would highly recommend him.

Dec 13, 2023

5.0

I would recommend he give eye contact to the patient more than caregiver - caregiver can be secondary when patient is able to talk for themselves.

Oct 24, 2023

Dr. And his team saved my life through treatment and follow-up. Great.

Sep 21, 2023

5.0

Dr. Chunkit Fung is professional . . . And friendly . . . Easy to "work" with . . .

Jul 21, 2023

5.0

Dr. Fung is a caring physician and sensitive to my needs. He does not rush me through a visit and we are able to have a discussion about my concerns and questions. At times he even calls me at home to follow up on my blood work. His concern for my well being is greatly appreciated. He is an extraordinary doctor and person.

Jun 28, 2023

5.0

Extremely nice doctor who seemed genuinely interested in learning about my cancer history and clearly spent time looking at my eight years of medical records.

Apr 12, 2023

5.0

I am most grateful that Dr. Fung is my GU oncologist. He is incredibly thorough and keeps me well informed.

Feb 15, 2023

5.0

As I said/wrote before he and all the physicians are great & I know they are doing & researching what's best for me, now & other future patients from the results of prior patients experiences/outcomes.

Feb 01, 2023

5.0

Dr. Fung Is an excellent doctor. He is caring and listens to all my questions. Shows and explains all my scans so I can understand them.

Jan 20, 2023

5.0

Dr. Fung is compassionate and sensitive to my concerns. We discussed the preferred treatment as well as additional testing. He is very thorough and the rationale for his recommendations are made abundantly clear. My daughter could not attend the visit but I had her on speaker phone. Dr. Fung made sure she was included and asked her several times during during the visit if she had questions. While getting into the details, he still help be see the big picture too. Finally, Dr. Fung is upbeat in a way that both realistic and inspires confidence.

Jan 05, 2023

5.0

Dr. Fung is the best doctor I have ever had. Very knowledgeable/ Very proactive in addressing issues.

Dec 21, 2022

5.0

This was my first visit with Dr. Fung [...] Dr. Fung did a thorough review of my health and listened carefully to my concerns and the information I provided. He presented four possible treatment plans in detail. He was sensitive to my feelings and fears. His concerns for my well-being were genuine and most welcome. I left the appointment feeling thankful and fortunate to have Dr. Fung treat my cancer.

Nov 30, 2022

5.0

Excellent.

Nov 19, 2022

5.0

Excellent.

Oct 12, 2022

5.0

[...]. I would give Dr. Fung the highest recommendation to anyone needing an oncologist.

Sep 24, 2022

5.0

This was my first visit. My experience with the doctor was very good.

Sep 11, 2022

5.0

Excellent provider.

Aug 08, 2022

5.0

Excellent Team

Jul 20, 2022

5.0

My provider was thorough and listened to my concerns

Jul 14, 2022

5.0

Outstanding assistance. Discussed all alternatives in detail.

Jun 30, 2022

Dr. Fung is "top notch" . . . ! Set up a follow-up CatScan indicated by my current PSA levels.

Jun 29, 2022

Doctor was very knowledgeable and spoke to me in simpler terms so I could understand

Jun 29, 2022

5.0

Very positive experience

Jun 19, 2022

5.0

Dr. Fung is excellent. His personality is an asset to his interaction with patients who can and are dealing with potentially serious conditions. He explains things very well, and asked questions to be sure he is fully understanding what his patients are saying. Over all great doctor and person.

May 18, 2022

Very very thorough. He explained things to me so that I could get a better idea of what I'm dealing with and it helped me greatly easing my mind of my condition.

May 09, 2022

5.0

Dr Fung is an outstanding Oncologist. He recommended a treatment for my Kidney Cancer that has resulted in a complete response. He always explains things in an understandable way. During my last visit he took the time to review my CT scans with me and answered all questions I had.

Apr 27, 2022

5.0

Good got in on time.

Apr 22, 2022

5.0

Dr. Fung is the "best"!

Apr 18, 2022

Very clear

Apr 07, 2022

Doctor Fung has always taken the time to explain everything in terms that we understand and made us comfortable with the treatments and tests needed to get me well.

Mar 17, 2022

5.0

Excellent experience with Dr. Fung. He explained my test results and answered all of my questions. He was very reassuring.

Mar 09, 2022

Dr. Fung is always very personable , understanding and direct!

Mar 05, 2022

5.0

Dr. Fung is very caring, knowledgeable, and spends the time to answer all questions thoroughly.

Feb 28, 2022

5.0

Dr Fung is always informative, and on top of that, has a sense of humor. It is a good experience to see him, and I am more confident about my progress after the visit.

Feb 16, 2022